前往化源商城

The Journal of Urology 1990-05-01

Sclerotherapy for hydroceles.

R K Rencken, M S Bornman, S Reif, I Olivier

文献索引:J. Urol. 143(5) , 940-3, (1990)

全文:HTML全文

摘要

Sclerotherapy with 3% sodium tetradecyl sulfate and 3.5% rolitetracycline on an outpatient basis was applied to 55 hydroceles. The over-all cure rate was 96% with an average followup of 13 months. Of the patients 64% were cured after only 1 sclerosant instillation. A post-sclerotherapy operation was necessary in 4% of the patients. Pain of a significant degree occurred after sclerotherapy in only 29% of the patients. Sclerotherapy appears to be an effective, economical and safe form of outpatient therapy for hydroceles.

相关化合物

结构式 名称/CAS号 全部文献
罗利环素 结构式 罗利环素
CAS:751-97-3